SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million
PR Newswire —
STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that SciBase and Castle Biosciences ("Castle") (NASDAQ: CSTL) have expanded their collaboration and license...